Newsroom | 1384 results

SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics and infectious disease vaccines, today announced that the Company will participate in the following investor conference: Piper Sandler 37th Annual Healthcare Conference (Fireside Chat) Tuesday, December 2, 2025 (12:30 p.m. ET) About Arcturus Founded in 2013 and based i...

DUBLIN--(BUSINESS WIRE)--The "mRNA Vaccines Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. The mRNA Vaccines Market is experiencing significant growth, evolving from USD 9.32 billion in 2024 to an anticipated USD 23.38 billion by 2032 with a robust CAGR of 12.17%. This market research report offers a comprehensive analysis on the progression of mRNA vaccine technologies, influencing strategic planning, competitive advantages, and identifying key opportu...

DUBLIN--(BUSINESS WIRE)--The "Global COVID-19 Diagnostic Market: Forecast by Technology, Product, Channel and Country, with Executive and Consultant Guides" has been added to ResearchAndMarkets.com's offering. The COVID-19 pandemic's impact lingers, transforming the landscape of respiratory diagnostics. While the immediate crisis has subsided, the virus remains, heralding a fiercely competitive industry eager to capitalize on a lucrative future. This new era sees testing progressively integrate...

UPPER NYACK, N.Y.--(BUSINESS WIRE)--GHLF Website/Hub provides U.S. patients with centralized vaccine information repository...

ORLANDO, Fla.--(BUSINESS WIRE)--Andor Health: WHAT: The U.S. hospital system faces total collapse from post-COVID fallout: over 100,000 nurses have quit since 2020, with 610,000 more planning to exit by 2027. Compounded by the opioid epidemic, migration to under-resourced rural areas, and rising tech-induced mental health disorders, emergency departments report 92% overload, straining overall capacity and fragmenting care. ThinkAndor®, Andor Health's Microsoft Teams-integrated platform, emerges...

ORLANDO, Fla.--(BUSINESS WIRE)--Andor Health: WHAT: The U.S. hospital system faces total collapse from post-COVID fallout: over 100,000 nurses have quit since 2020, with 610,000 more planning to exit by 2027. Compounded by the opioid epidemic, migration to under-resourced rural areas, and rising tech-induced mental health disorders, emergency departments report 92% overload, straining overall capacity and fragmenting care. ThinkAndor®, Andor Health's Microsoft Teams-integrated platform, emerges...

UPPER NYACK, N.Y.--(BUSINESS WIRE)--Patients and physicians can find convenient vaccination pharmacy locations with new GHLF tool...

LOS ANGELES--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today shared promising results from the first-of-its-kind clinical trial published today in The Lancet peer-reviewed journal eClinicalMedicine demonstrating that daily supplementation with Niagen®, Niagen Bioscience’s patented nicotinamide riboside (NR) ingredient, significantly increased NAD+ levels and improved exe...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: UBS Global Healthcare Conference on Monday, November 10 at 11:00 AM Eastern Time Jefferies Global Healthcare Conference in London on Wednesday, November 19 at 2:00 PM Greenwich Mean Time Citi’s Global Healthcare Conference on Tuesday, December 2 at 11:15 AM Eastern Time Annual Evercore Healthcare Conference on Wednesday, December...

SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics and infectious disease vaccines, today announced that the Company will participate in the following investor conferences: Guggenheim 2nd Annual Healthcare Innovation Conference (Fireside Chat) Wednesday, November 12 (11:30 a.m. ET) Jefferies Global Healthcare Conferenc...